New York State Teachers Retirement System Sells 5,781 Shares of Progyny, Inc. (NASDAQ:PGNY)

New York State Teachers Retirement System trimmed its holdings in shares of Progyny, Inc. (NASDAQ:PGNYFree Report) by 7.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,700 shares of the company’s stock after selling 5,781 shares during the period. New York State Teachers Retirement System owned 0.08% of Progyny worth $1,218,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. State of Alaska Department of Revenue raised its stake in shares of Progyny by 397.7% during the third quarter. State of Alaska Department of Revenue now owns 44,819 shares of the company’s stock worth $751,000 after buying an additional 35,813 shares during the last quarter. Louisiana State Employees Retirement System increased its stake in Progyny by 62.4% in the third quarter. Louisiana State Employees Retirement System now owns 38,000 shares of the company’s stock valued at $637,000 after purchasing an additional 14,600 shares in the last quarter. International Assets Investment Management LLC increased its stake in Progyny by 1,576.0% in the third quarter. International Assets Investment Management LLC now owns 2,565,118 shares of the company’s stock valued at $42,991,000 after purchasing an additional 2,412,068 shares in the last quarter. Cetera Trust Company N.A increased its stake in Progyny by 30.0% in the third quarter. Cetera Trust Company N.A now owns 7,210 shares of the company’s stock valued at $121,000 after purchasing an additional 1,665 shares in the last quarter. Finally, Everence Capital Management Inc. bought a new stake in Progyny in the third quarter valued at approximately $173,000. 94.93% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PGNY has been the subject of several recent analyst reports. JMP Securities downgraded shares of Progyny from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 19th. BTIG Research downgraded shares of Progyny from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 7th. Canaccord Genuity Group lowered their target price on shares of Progyny from $24.00 to $18.00 and set a “hold” rating for the company in a research note on Friday, September 20th. Canaccord Genuity Group cut shares of Progyny from a “buy” rating to a “hold” rating and reduced their price target for the company from $37.00 to $24.00 in a report on Wednesday, August 7th. Finally, Leerink Partnrs cut shares of Progyny from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 7th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $27.73.

Get Our Latest Analysis on Progyny

Progyny Trading Up 0.5 %

Shares of PGNY opened at $16.61 on Friday. Progyny, Inc. has a 12 month low of $13.93 and a 12 month high of $42.08. The firm has a fifty day simple moving average of $18.14 and a 200 day simple moving average of $23.90. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of 26.37, a PEG ratio of 1.55 and a beta of 1.44.

About Progyny

(Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Featured Stories

Want to see what other hedge funds are holding PGNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Progyny, Inc. (NASDAQ:PGNYFree Report).

Institutional Ownership by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.